RIVERVEST
RiverVest is a venture capital firm which focuses on identifying and shaping early stage life science companies that creates shareholder values. Their teamโs domain experience allows them to identify, find, and actively incubate promising life science companies in the medical device and biopharmaceutical industries. It provides practical advice and strategic leadership to help entrepreneurs drive early-stage companies forward. It also invests in selected later-stage life science companies to diversify risk and maximize portfolio returns. RiverVest is a U.S.-based company that was founded in 2000 by Jay W. Schmelter.
RIVERVEST
Industry:
Finance Financial Services Venture Capital
Founded:
2000-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
Current Advisors List
Floyd Bloom Member of the Scientific Advisory Board @ RiverVest Advisor
Current Employees Featured
Marilyn J. Slavich
Marilyn J. Slavich Consultant for Rivervest Venture Capital @ RiverVest Consultant for Rivervest Venture Capital
Nancy Hong
Nancy Hong Managing Director @ RiverVest Managing Director 2016-04-01
Derek K. Rapp
Derek K. Rapp Managing Director @ RiverVest Managing Director 2019-07-01
Andrew B. Craig III
Andrew B. Craig III Retired Special Limited Partner @ RiverVest Retired Special Limited Partner
Kelly K. Cathey
Kelly K. Cathey Office Manager @ RiverVest Office Manager
Corrin J. Short
Corrin J. Short Executive Assistant @ RiverVest Executive Assistant
John McKearn
John McKearn Managing Director @ RiverVest Managing Director 2008-04-01
Michael Berman
Michael Berman Venture Partner @ RiverVest Venture Partner 2014-01-01
Sivan Rosen Weitzman
Sivan Rosen Weitzman CFO @ RiverVest CFO 2019-01-01
Niall O&s;Donnell
Niall O'Donnell Managing Director @ RiverVest Managing Director 2014-01-01
Founder
Jay W. Schmelter
Thomas Melzer
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-08-16 | Bluejay Therapeutics | RiverVest investment in Series B - Bluejay Therapeutics | 41 M USD |
2021-12-30 | Good Therapeutics | RiverVest investment in Series B - Good Therapeutics | 8 M USD |
2021-11-23 | Venture Med Group | RiverVest investment in Convertible Note - Venture Med Group | N/A |
2021-11-02 | Biolinq | RiverVest investment in Series B - Biolinq | 100 M USD |
2021-10-19 | Scout Bio | RiverVest investment in Series B - Scout Bio | 33 M USD |
2021-07-15 | Wugen | RiverVest investment in Series B - Wugen | 172 M USD |
2021-06-23 | Glycomine | RiverVest investment in Series B - Glycomine | 35 M USD |
2021-06-01 | Standard Bariatrics | RiverVest investment in Series B - Standard Bariatrics | 35 M USD |
2021-05-18 | Sparrow Pharmaceuticals | RiverVest investment in Series A - Sparrow Pharmaceuticals | 50 M USD |
2021-04-27 | Arch Oncology | RiverVest investment in Series C - Arch Oncology | 105 M USD |
Key Employee Changes
Date | New article |
---|---|
2020-09-23 | COVID-19 losses force Wichita Riverfest to cut a third of its staff, including new CEO |